Drug intelligence / Profile preview

1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine

Development stage
Unknown
Modality
Small Molecules
01

Overview

**1-[ (2,6-Difluorophenyl) sulfonyl ] -4-[ (2,3-dihydro - 1 , 4 - benzodioxin - 6 - yl ) sulfonyl ] piperazine** is a synthetic small molecule belonging to the benzenesulfonamide class. It is referenced in chemical and pharmaceutical databases as an experimental compound and has been assigned the code name ML285. The compound features two sulfone groups attached to a piperazine core with difluoro-substituted phenylene and benzodioxin moieties. There is no evidence of clinical development or approved therapeutic use; its mechanism of action and biological targets are not described in public drug databases[1][2][7]. It appears primarily in research contexts as a chemical probe or screening hit.

Other names
1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine1-(2,6-difluorobenzenesulfonyl)-4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazine1-(2,6-difluorophenyl)sulfonyl–4–(2,3–dihydro–1,4–benzodioxin–6–ylsulfonyl)piperazineCHEBI:93004

Beyond the preview

Go deeper on 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call